FDA Holds Workshop on Rare Disease Clinical Investigations

The FDA Rare Disease Innovation Hub and Duke Margolis co-convene a public workshop at 9 a.m. ET on Sept. 29 on statistical considerations in the design, conduct, and analysis of clinical investigations for rare disease medical products.